Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 106 AL 120

Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective

Grover P, Rohilla S, Bhardwaj M, Mehta L, Malhotra A.

Curr Top Med Chem. 2023;23(13):1221-1259. doi: 10.2174/1568026623666230406084315.

The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies

Lozupone M, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Panza F.

Expert Opin Drug Discov. 2023 May;18(5):515-526. doi: 10.1080/17460441.2023.2200245. Epub 2023 Apr 11.

The future of alzheimer disease immunotherapies in Saudi Arabia: Consensus statement of the Saudi Chapter of Cognitive and Behavioral Neurology

Tayeb HO, Khallaf RA, Muayqil TA, Alkeridy WA, Alibrahim FS, Alfaify OA, Qadi N, Tarazi FI.

Neurosciences (Riyadh). 2023 Apr;28(2):77-84. doi: 10.17712/nsj.2023.2.20220133.

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?

Petrovskaya A, Tverskoi A, Medvedeva A, Nazarova M.

Commun Biol. 2023 Apr 14;6(1):416. doi: 10.1038/s42003-023-04717-1.

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Lanctôt KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N.

Int Psychogeriatr. 2023 Nov;35(11):664-672. doi: 10.1017/S1041610223000327. Epub 2023 Apr 17.

Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer's Disease from 2004 to 2022

Wang R, Zhu Y, Qin LF, Xu ZG, Gao XR, Liu CB, Xu GT, Chen YZ.

Dement Geriatr Cogn Disord. 2023;52(2):47-73. doi: 10.1159/000528886. Epub 2023 Apr 17.

Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control

Li J, Zhang F, Zhao L, Dong C.

Rev Neurosci. 2023 Apr 20;34(6):695-718. doi: 10.1515/revneuro-2023-0006. Print 2023 Aug 28.

Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study

Mateev E, Kondeva-Burdina M, Georgieva M, Zlatkov A.

J Mol Graph Model. 2023 Jul;122:108471. doi: 10.1016/j.jmgm.2023.108471. Epub 2023 Apr 14.

Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Mummery CJ, Börjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, Jonsson M, Schneider A, Rinne JO, Ludolph AC, Bodenschatz R, Kordasiewicz H, Swayze EE, Fitzsimmons B, Mignon L, Moore KM, Yun C, Baumann T, Li D, Norris DA, Crean R, Graham DL, Huang E, Ratti E, Bennett CF, Junge C, Lane RM.

Nat Med. 2023 Jun;29(6):1437-1447. doi: 10.1038/s41591-023-02326-3. Epub 2023 Apr 24.

Improving the Treatment Effect of Carotenoids on Alzheimer's Disease through Various Nano-Delivery Systems

Su W, Xu W, Liu E, Su W, Polyakov NE.

Int J Mol Sci. 2023 Apr 21;24(8):7652. doi: 10.3390/ijms24087652.

Current study on diagnosis and treatment of Alzheimer's disease by targeting amyloid b-protein

Hua KY, Zhao WJ.

Folia Neuropathol. 2023;61(1):8-15. doi: 10.5114/fn.2022.119778.

Mesenchymal Stem Cells for Treating Alzheimer's Disease: Cell Therapy and Chemical Reagent Pretreatment

Zhang K, Du X, Gao Y, Liu S, Xu Y.

J Alzheimers Dis. 2023;93(3):863-878. doi: 10.3233/JAD-221253.

Effects of physical activity interventions on executive function in older adults with dementia: A meta-analysis of randomized controlled trials

Zeng Y, Wang J, Cai X, Zhang X, Zhang J, Peng M, Xiao D, Ouyang H, Yan F.

Geriatr Nurs. 2023 May-Jun;51:369-377. doi: 10.1016/j.gerinurse.2023.04.012. Epub 2023 Apr 30.

Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy

Tseng PT, Zeng BS, Suen MW, Wu YC, Correll CU, Zeng BY, Kuo JS, Chen YW, Chen TY, Tu YK, Lin PY, Carvalho AF, Stubbs B, Li DJ, Liang CS, Hsu CW, Sun CK, Cheng YS, Yeh PY, Wu MK, Shiue YL, Su KP.

Brain Behav Immun. 2023 Jul;111:352-364. doi: 10.1016/j.bbi.2023.04.017. Epub 2023 May 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias